ELDERPHARM

Elder Health Care Limited has submitted to the Exchange, vide letter dated April 23, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Ltd. has submitted to the Exchange vide letter dated April 18, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Health Care Limited has submitted to the Exchange vide its letter dated April 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has submitted to the Exchange vide letter dated April 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Health Care Limited has submitted to the Exchange vide letter dated April 08, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Limited has submitted to the Exchange vide letter dated April 04, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shalini Kumar has submitted to the Exchange vide letter dated March 22, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company have decided to extend the Financial Year 2012-13 by three months so as to end on June 30, 2013 instead of March 31, 2013. Accordingly the Company will be preparing its annual accounts for the period of 15 months from April 01, 2012 to June 30, 2013.

Elder Pharmaceuticals Limited has informed the Exchange regarding the Press Release dated March 06, 2013, titled" Elder Pharmaceuticals Limited to Create Joint Venture with KOSE Corporation of Japan".

Shalini Kumar has submitted to the Exchange vide letter dated February 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Ltd has submitted to the Exchange vide letter dated February 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Limited has submitted to the Exchange vide letter dated February 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt ltd has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide its letter dated February 20, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Limited has submitted to the Exchange vide letter dated February 20, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Ltd. has submitted to the Exchange vide letter dated February 20, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2012.

Shalini Kumar has submitted to the Exchange vide letter dated February 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated February 05, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Limited has submitted to the Exchange vide its letter dated January 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Ltd has submitted to the Exchange vide its letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings PVT Ltd has submitted to the Exchange vide letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Ltd has submitted to the Exchange vide its letter dated January 15, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide its letter dated January 10, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that on December 24, 2012 the Company has signed a Memorandum of Understanding with Holding PharmEco, a Russian company, for establishing a Joint Venture company in Russia for setting up manufacturing facility/ies for pharmaceutical formulations / APIs. Further the Company has submitted a Copy of press release dated December 24, 2012.

Indarts Exports PVT. Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niti Saxena has submitted to the Exchange vide letter dated December 12, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports PVT. Ltd has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Spurt in Volume : Substantial increase in trading volumes have been observed in Elder Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "In the recent past there has not been any development in the Company or any information/announcement (including pending announcement) which in our opinion may have a bearing on the price/volume behavior in t

Niti Saxena has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings PVT Ltd has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 05, 2012 titled "Elder Pharmaceuticals Ltd. has received the Certificate of Suitability (cos) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for DIOSMIN API.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2012.

Elder Pharmaceuticals Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on September 28, 2012.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.

Elder Pharmaceuticals Limited has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 28, 2012. Further the Share transfer books closed from September 20, 2012 to September 28, 2012 (both days inclusive) for payment of dividend.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 09, 2012 have re-appoint Mr. Yusuf Karim Khan as Executive Director for a period of five years w.e.f. August 28, 2012, subject to approval of the shareholders at the ensuing Annual General Meeting and appropriate authorities, if any.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 09, 2012 have recommend for consideration of Shareholders declaration of dividend @ 30% i.e. Rs.3/- per share of Rs.10/- each.

Elder Pharmaceuticals Limited has informed the Exchange regarding the outcome of Board Meeting held on August 02, 2012.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated June 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended March 31,2012.

Elder Pharmaceuticals Limited has informed the Exchange that with reference to the news item "Elder Pharma weighs sale of nutrition business" appearing on various media websites, the Company hereby clarify that the Company has no intentions to sell any business nor is in any discussion with any party. The Company's Joint Managing Director has already denied in the said news item that the Company was looking to sell any Business.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Pvt Ltd has submitted to the Exchange vide its letter dated April 27, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated March 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for pledge of 25000 shares.